Fact CheckerSign in

NCT04758390Completed

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

Source: ClinicalTrials.gov · Last updated 20 Jan 2025

Brief summary (registry, in English)

To achieve an AIDS-free generation, there is a critical need for programs which go beyond individual-level behavior change to reduce HIV and STI infections among adolescent girls and young women in sub-Saharan Africa. Informed, Motivated, Aware, and Responsible Adolescents and Adults (IMARA) is an evidence-based HIV-prevention intervention for adolescent girls and young women (AGYW) and their female caregivers, which has been adapted for a South African audience. The study will test whether AGYW receiving IMARA will have fewer sexually-transmitted infections (STI) and greater acceptance of HIV testing and counseling (HTC) and pre-exposure prophylaxis (PrEP) at 6-month follow-up compared to AGYW assigned to the health-promotion control intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
1290 (actual)
First submitted
11 Feb 2021
Start date
2 Oct 2021
Primary completion date
7 Apr 2024
Lead sponsor
University of Illinois Chicago
Diseases
HIV
NCT number
NCT04758390

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1290
  • From 2 Oct 2021 to the primary completion date, 7 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • AGYW and FC will be excluded from the study if they are: a) unable to understand the consent/assent process and provide written informed consent; b) currently enrolled in another research study addressing HIV/STIs/PrEP.

Other

  • AGYW will be excluded from the study if they do not have a FC to participate in the study.
  • AGYW and FC must agree to participate as a dyad. AGYW refusal will supersede FC consent.

Who the study is looking for

  • female;
  • 15-19 years-old;
  • residing in Klipfontein/Mitchells Plain (K/MP);
  • speak isiXhosa or English or a combination of these languages;
  • willing to have biometric data collected.
  • identified by AGYW as a FC;
  • 24 years and older;
  • living with or in daily contact with the AGYW;
  • speak isiXhosa or English or a combination of these languages;
  • willing to have biometric data collected.

Age in the registry: 15 years to 19 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Desmond Tutu Health Foundation
Coordinator of this site? Confirm its status
Cape TownSouth AfricaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.